/PRNewswire/ -- ICU Medical, Inc. (Nasdaq:ICUI) today announced the introduction of the NanoClave  low-profile neutral displacement needlefree connector, designed to keep neonatal and pediatric patients safe by minimizing flush volumes while providing a safe and effective microbial barrier. NanoClave will be debuted at the Association for Vascular Access (AVA) Annual Scientific Meeting  in San Antonio, TX on , the National Association of Neonatal Nurses (NANN) Annual Educational Conference  in Palm Springs, CA on October 17, 2012, and Infectious Disease Week (ID Week)  in San Diego, CA on October 17, 2012.
NanoClave helps clinicians keep neonatal and pediatric patients safe from infection while effectively managing their fluids. The compact NanoClave combines a straight fluid path and a residual volume of only 0.02 mL with a clear housing that permits visualization of the fluid path to confirm the connector has been completely flushed after blood draws or administration. NanoClave also includes the same split-septum, straight internal fluid path technology used in ICU Medical's complete portfolio of needlefree vascular access devices, which has been clinically-proven to provide an effective microbial barrier against bacteria transfer and contamination.
"We switched to the NanoClave T-connector extension set in both NICU and PICU not only because of the small, smooth profile and extremely low fluid volumes required to flush, but also because it allowed us to continue using a split-septum design, but with no extra parts like our old T-connector," says Sheryl A. Ruth, R.N.-C, M.S.,Nurse Manager at UC Davis Children's Hospital, who specializes in the care of high-risk infants. "Also, the proven Clave technology really appealed to us from an infection control standpoint. We've had great success so far."
Effectively managing patient fluids and electrolyte status is one of the most critical elements of neonatal infusion therapy and is vital to a healthy transition from the in-utero to ex-utero environment. Neonates face an increased risk for both dehydration and fluid overload, resulting from low renal capacity for urine concentration or dilution. As a result, clinicians must carefully calculate and monitor neonatal fluid and electrolyte requirements. Reducing the volume of flush solution required to clear an IV connector of blood components may help clinicians in these efforts to maintain appropriate patient fluid balance.